92 results
8-K/A
EX-99.1
GMDAQ
Gamida Cell Ltd
5 Apr 24
Other Events
5:16pm
results from the Phase 1 clinical study at the Annual Meeting of the American Society of Hematology, or ASH. The data from the first 35 patients … Society of Hematology the Company reported two-year follow-up data from this clinical trial on outcomes and cytokine biomarkers associated
8-K
EX-99.1
GMDAQ
Gamida Cell Ltd
27 Mar 24
Gamida Cell Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Company Update
7:30am
) Meetings of the American Society for Transplantation and Cellular Therapy (ASTCT®) and the Center for International Blood and Marrow Transplant Research … Perspective” was published online in American Society of Hematology’s Blood Advances. The publication quantified costs of care among commercially
8-K
EX-10.1
GMDAQ
Gamida Cell Ltd
27 Mar 24
Gamida Cell Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Company Update
7:30am
(collectively, the “Consenting Secured Noteholders”) and Wilmington Savings Fund Society, FSB, in its capacity as administrative agent and collateral … Savings Fund Society, FSB, in its capacity as trustee under the Senior Notes Indenture (the “Senior Notes Trustee”).
RECITALS
WHEREAS, the Company
8-K
EX-99.1
GMDAQ
Gamida Cell Ltd
14 Nov 23
Gamida Cell Reports Third Quarter 2023 Financial Results and Provides Company Update
12:00am
is available online on the Transplantation and Cellular Therapy website.
Data presented at Society for Immunotherapy of Cancer’s (SITC) Annual … for the unique cell culture kinetics of NAM-NK cells.
Upcoming participation in the American Society of Hematology (ASH) Annual Meeting and Exposition
8-K
EX-99.1
8own0tn q9q
14 Aug 23
Gamida Cell Reports Second Quarter and First Half 2023 Financial Results and Provides Company Update
7:30am
DEFR14A
tdv7pnwr is3759
9 May 23
Revised proxy
5:25pm
8-K
EX-4.1
d82z25e bvx1ophp60y
21 Apr 23
Gamida Cell Announces Launch of Public Offering of Securities
7:19am
424B5
cw8tsj
20 Apr 23
Prospectus supplement for primary offering
5:27pm
424B5
koeggbsl0x
19 Apr 23
Prospectus supplement for primary offering
6:46am
8-K
EX-99.1
sgh lvde78b4aq
17 Apr 23
Gamida Cell’s Allogeneic Cell Therapy Omisirge® (omidubicel-onlv) Receives FDA Approval
5:29pm
8-K
EX-10.2
awrsxjdw w63uu
12 Dec 22
Gamida Cell Announces Closing of $25 Million Financing with Highbridge
7:15am